Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial
Too much 'bad' cholesterol in the bloodstream – that's the low-density lipoprotein (LDL) type – can contribute to plaque buildup in the arteries, increasing the risk of cardiovascular problems like heart attacks and strokes.
Next post
The Rise of Robinhood: How a Small Brokerage Became a Market Phenomenon
